Boosting the Fight Against Childhood Cancer with AI
Shares of Tempus AI rose following the executive order promoting the use of AI to develop solutions for pediatric cancer.

Already have an account? Sign in.
Shares of Tempus AI rose following the executive order promoting the use of AI to develop solutions for pediatric cancer.
Morgan Stanley analyst remains confident in Elf Beauty's growth despite Rhode brand's lower-than-expected June quarter revenue, citing strong September Sephora launch and maintaining $170 target.
CoreWeave shares fall after top shareholder Magnetar Financial dumps over $500 million in stock within a week, despite previously praising the AI infrastructure company.
JPMorgan raises RAPT stock rating to Overweight with $55 target after Phase 2 trial success. Stock jumps 17% on positive chronic urticaria treatment data.